As of January 22, 2025, Renovaro Biosciences (RENB) has a market cap of $0.13 billion USD. According to our data, Renovaro Biosciences is ranked No.7513 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.13 B |
-4.68%
|
Dec 31, 2024 | $0.13 B |
-73.63%
|
Dec 29, 2023 | $0.50 B |
207.77%
|
Dec 30, 2022 | $0.16 B |
-85.87%
|
Dec 31, 2021 | $1.16 B |
147.12%
|
Dec 31, 2020 | $0.47 B |
-41.24%
|
Dec 31, 2019 | $0.80 B |
-28.29%
|
Dec 31, 2018 | $1.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Microsoft
MSFT
|
$3.317 T |
0.045 M
|
USA
|
Apple
AAPL
|
$3.366 T |
0.020 M
|
USA
|
Amazon
AMZN
|
$2.471 T |
-0.129 M
|
USA
|
Meta (Facebook)
META
|
$1.574 T |
214.790 B
|
USA
|
IBM
IBM
|
$206.44 B |
0.001 M
|
USA
|
Oracle
ORCL
|
$515.26 B |
-0.015 M
|
USA
|
Salesforce
CRM
|
$318.32 B |
-0.005 M
|
USA
|
SAP
SAP
|
$318.45 B |
0.006 M
|
Germany
|
Adobe
ADBE
|
$190.37 B |
0.002 M
|
USA
|
ServiceNow
NOW
|
$232.14 B |
0.002 M
|
USA
|
Workday
WDAY
|
$67.43 B |
13.181 B
|
USA
|
Intuit
INTU
|
$171.22 B |
-0.008 M
|
USA
|
Atlassian
TEAM
|
$67.93 B |
25.818 B
|
Australia
|
Zoom
ZM
|
$24.30 B |
3.520 B
|
USA
|
Market Cap | = | RENB Stock Price | * | RENB Shares Outstanding |
= | $0.80 | * | 0.16 B | |
= | $0.13 B |